TMCnet News
Ovid Therapeutics to Participate in the JMP Securities 2017 Life Sciences ConferenceNEW YORK, June 12, 2017 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines for patients with rare neurological disorders, today announced that Yaron Werber, MD, chief business and financial officer of Ovid, will participate in the upcoming JMP Securities 2017 Life Sciences Conference. Dr. Werber will participate in a panel discussion entitled “The Emerging Landscape of Orphan / CNS Disorders” on Tuesday, June 20, 2017 at 1:00 p.m. EDT. The conference will be held at the St. Regis Hotel in New York, NY. About Ovid Therapeutics For more information on Ovid, please visit http://www.ovidrx.com/. Ovid Contacts: Investors: Burns McClellan Steve Klass, 212-213-0006 [email protected] Media: Pure Communications, Inc. Katie Engleman, 910-509-3977 [email protected] |